According to the World Health Organization (WHO), approximately 296 million people globally live with hepatitis B, with most unaware of their infection.
Seqster has attracted another pharma partner for its patient data technology, which aims to improve care through better access and understanding of patient-level real-world data (RWD).
The immediate threat to patient care from COVID-19 has diminished with the passing of the acute phase of the pandemic, but its impact continues to be stubbornly significant.